mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.02 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |